Search results for " capacity"
Article
Biopharma Outsourcing Activities Update
BioPlan Associates,11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, Preliminary data (Rockville, Md., April 2014).
About the Author
Eric Langer is pres…
Article
Brazil Emerges as Global Biopharm Collaborator
The government is establishing key partnerships with local and multinational, private, and public companies, and is funding local production capacity expansions for public and private companies. Brazi…
Article
A Closer Look at Affinity Ligands
Using traditional resins with small pore size leads to low binding capacity because of very low diffusion rates into the pores of the resin. LV particles are also exceptionally sensitive to pH, salt c…
Article
Top Tips for Successful Development of Antibody Chromatography Processes
In this interview, Jakob Liderfelt, Product Manager at Cytiva, discusses main challenges faced during chromatography process development for mAbs and mAb variants such as fragments and bispecific a…
Article
Discovering the unknown: How does in silico process development change PD scientists’ work?
Enhancing quality, capacity, speed and flexibility throughout the process are what makes it difference when developing a biopharmaceutical for successful market entry. By simulating the process to gai…
Article
Chromatography innovations for the diversified antibody pipeline
Our MabSelect™ VH3 affinity resin interacts with the variable heavy chain of the VH3 sequence family of human antibody, delivering high binding capacity and efficient separation of product-related imp…
Article
Get more from UNICORN™ software with plug-in extensions
Access extensions for UNICORN software from the new Cytiva Marketplace, including a free extension that performs Dynamic Binding Capacity (DBC) calculations for breakthrough volume and QB valu…
Article
Cytiva Acquires Chromatography Resins Manufacturing Facility in Muskegon, Michigan
Cytiva has acquired a new chromatography resins manufacturing site in the United States as part of its $1.5 billion capacity expansion investment.
LEARN MORE >>
Article
Cytiva expanding US operations
Cytiva, a global life sciences leader, is investing in additional resins manufacturing operations outside of Sweden, for the first time in the company’s history, with the acquisition of a …
Article
Analytical Considerations for Successful Upstream Process Development with Spivey and Lane
BioPharm International: During scale up, because I know that part of the point of the Devens facility was to increase capacity during scale up, have the kinds of things that go wrong changed?
Dr…